NCT02434250 Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy Status COMPLETED Phase NA
NCT02419508 SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) Status COMPLETED Phase PHASE4
NCT02390245 Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study Status COMPLETED Phase NA
NCT02379208 Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle Glaucoma Status UNKNOWN Phase N/A
NCT02348476 A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase N/A
NCT02339584 Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) Status COMPLETED Phase PHASE3
NCT02338362 Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma Status COMPLETED Phase PHASE4
NCT02325518 Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution Status COMPLETED Phase PHASE4
NCT02312544 Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE2
NCT02295358 The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface Status WITHDRAWN Phase N/A
NCT02278614 Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients Status COMPLETED Phase PHASE3
NCT02250651 Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02247804 Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02246764 Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02207621 Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02207491 Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3